Evidence map›Paper›PMID 28602015›Full record

ArticleInternational ophthalmology2018

Clinical and genetic analysis of Indian patients with NDP-related retinopathies.

Dhandayuthapani Sudha, Aparna Ganapathy, Puja Mohan, Ashraf U Mannan, Shuba Krishna, Srividya Neriyanuri, Meenakshi Swaminathan, Pukhraj Rishi, Subbulakshmi Chidambaram, Jayamuruga Pandian Arunachalam

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. NDP-related retinopathies: clinical phenotype of female carriers.The British journal of ophthalmology · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Dhandayuthapani SudhaSN ONGC Department of Genetics and Molecular Biology, Vision Research Foundation, 41, College Road, Nungambakkam, Chennai, 600006, India.
Aparna GanapathyStrand Life Sciences, Hebbal, Bengaluru, India.
Puja MohanStrand Life Sciences, Hebbal, Bengaluru, India.
Ashraf U MannanStrand Life Sciences, Hebbal, Bengaluru, India.
Shuba KrishnaStrand Life Sciences, Hebbal, Bengaluru, India.
Srividya NeriyanuriElite School of Optometry, Unit of Medical Research Foundation, Chennai, India.
Meenakshi SwaminathanDepartment of Pediatric Ophthalmology, Medical Research Foundation, Chennai, India.
Pukhraj RishiShri Bhagwan Mahavir Vitreo-Retinal Services, Sankara Nethralaya, Medical Research Foundation, Chennai, India.
Subbulakshmi ChidambaramR.S. Mehta Jain Department of Biochemistry and Cell Biology, Vision Research Foundation, Chennai, India.
Jayamuruga Pandian ArunachalamSN ONGC Department of Genetics and Molecular Biology, Vision Research Foundation, 41, College Road, Nungambakkam, Chennai, 600006, India. ajmpandian@gmail.com.
Strand Life Sciences (India) · INElite School of Optometry · INIndia Diabetes Research Foundation · INOil and Natural Gas Corporation (India) · INSankara Nethralaya · INSASTRA University · INSri Balaji Vidyapeeth University · IN

Funding

Department of Biotechnology , Ministry of Science and Technology BT/PR15111/GBD/27/322/2011Vision Research Foundation 202-2009-P
6 · The paper itself

Abstract

purposeNDP-related retinopathies are a group of X-linked disorders characterized by degenerative and proliferative changes of the neuroretina, occasionally accompanied with varying degrees of mental retardation and sensorineural hearing loss. NDP is the predominant gene associated with NDP-related retinopathies. The purpose of this study was to report the clinical and genetic findings in three unrelated patients diagnosed with NDP-related retinopathies.

methodsThe patients underwent complete ophthalmic examination followed by genetic analyses. NDP gene was screened by direct sequencing approach. Targeted resequencing of several other ocular genes was carried out in patient samples that either indicated NDP gene deletion or tested negative for NDP mutation. Gene quantitation analysis was performed using real-time PCR.

resultsThe whole NDP gene was deleted in patient I, while a missense NDP mutation, c.205T>C, was identified in patient II, and both had classical Norrie disease ocular phenotype (with no other systemic defects). Patient III who was diagnosed with familial exudative vitreoretinopathy did not show any mutation in the known candidate genes as well as in other ocular genes tested.

conclusionsThe patient with whole NDP gene deletion did not exhibit any apparent extraocular defects (like mental retardation or sensorineural hearing loss) during his first decade of life, and this is considered to be a notable finding. Our study also provides evidence emphasizing the need for genetic testing which could eliminate ambiguities in clinical diagnosis and detect carrier status, thereby aiding the patient and family members during genetic counseling.

Indexed as

Abnormalities, MultipleMutation, MissenseBlindnessChildChild, PreschoolDNADNA Mutational AnalysisEye ProteinsFemaleGenetic Diseases, X-LinkedHumansInfantMaleMicroscopy, AcousticNerve Tissue ProteinsNervous System DiseasesDNAEye ProteinsNDP protein, humanNerve Tissue ProteinsFEVRMutationNDP geneNDP-related retinopathiesNorrie disease

Identifiers

PMID28602015
OpenAlexW2621971954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.